Acknowledgements
MYELOMA
This project was supported by the Dietmar-Hopp Foundation. The GMMG-MM5 trial was supported by grants from Celgene, Janssen-Cilag, Chugai and The Binding Site. The GMMG thanks the Koordinierungszentrum für Klinische Studien (KKS) Heidelberg for the support of the trial and data monitoring. The GMMG also thanks all investigators, study centers and participating patients. E.K.M. was funded by the International Myeloma Society (IMS) Career Development Award 2021.